Retagliptin Uses, Dosage, Side Effects and more
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
| Trade Name | Retagliptin |
| Generic | Retagliptin |
| Type | |
| Formula | C19H18F6N4O3 |
| Weight | Average: 464.368 Monoisotopic: 464.128309434 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
